Quick Takeaways
- Hudson Bay Capital Management LP filed SCHEDULE 13G/A for Aptevo Therapeutics Inc. Common Stock, $0.001 par value (APVO).
- Disclosed ownership: 5%.
- Date of event: 31 Dec 2024.
Hudson Bay Capital Management LP - 31 Dec 2024 SCHEDULE 13G/A Report for Aptevo Therapeutics Inc. Common Stock, $0.001 par value (APVO)
- Filing Manager
- Hudson Bay Capital Management LP
- Reporting Manager
- Hudson Bay Capital Management LP
- Symbol
- APVO
- Shares outstanding
- 1,535,030 shares
- Disclosed Ownership
- 76,598 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Feb 2025, 18:58:24 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Hudson Bay Capital Management LP disclosed 5% ownership in Aptevo Therapeutics Inc. Common Stock, $0.001 par value (APVO) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2025, 18:58.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 5% | 76,598 | 0 | 76,598 | /s/ Sander Gerber | Sander Gerber, Authorized Signatory | |
| Sander Gerber | 5% | 76,598 | 0 | 76,598 | /s/ Sander Gerber | Sander Gerber, Individually |